Amgen’s New Study on Xaluritamig: A Potential Game-Changer in Prostate Cancer Treatment?

5 days ago 3

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 1b study titled A Phase 1b Open-label, Multicenter Study E...

1. Homepage
2. Prostate Cancer
3. Amgen’s New Study on Xaluritamig: A Potential Game-Changer in Prostate Cancer Treatment?